Evaluation of Immediate Versus Delayed Loading of Dental Implants With a Modified Surface

NCT ID: NCT00782171

Last Updated: 2017-06-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

266 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-07-31

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the performance of a new dental implant with a modified surface in different loading protocols.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a post-market randomized study whereby each patient will receive 1 to 4 implants placed in the posterior maxilla or mandible. The primary objective of this randomized open study is to evaluate the performance in immediate and delayed loading (4 weeks) of Straumann standard solid screw 4.1mm and the 4.8 mm diameter wide neck implants with a new surface. These implants will support single crowns or 2 to 4 unit bridge restorations in the posterior maxilla or mandible and the treatment will be evaluated for the immediate and delayed loading procedures at one year post surgery. Patients will be allocated into two groups and then randomized into immediate or delayed loading arms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Partial Edentulism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Immediate Loading

SLActive dental implant(s) will be restored with a temporary restoration on the day of surgery.

Group Type ACTIVE_COMPARATOR

SLActive dental implant

Intervention Type DEVICE

Straumann® SLActive implants will be placed. Implants in Arm 1 will be restored with a temporary restoration on the day of surgery.

Implants in Arm 2 will receive healing caps immediately after surgery and a provisional restoration will be placed between day 28 to day 34 post-surgery.

In both arms, the final restoration will be placed between 140 and 160 days (20 to 23 weeks) post-surgery.

Early Loading

Healing caps will be placed on the SLActive dental implant(s) immediately after surgery. A provisional restoration will be placed between day 28 to day 34 post surgery

Group Type ACTIVE_COMPARATOR

SLActive dental implant

Intervention Type DEVICE

Straumann® SLActive implants will be placed. Implants in Arm 1 will be restored with a temporary restoration on the day of surgery.

Implants in Arm 2 will receive healing caps immediately after surgery and a provisional restoration will be placed between day 28 to day 34 post-surgery.

In both arms, the final restoration will be placed between 140 and 160 days (20 to 23 weeks) post-surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SLActive dental implant

Straumann® SLActive implants will be placed. Implants in Arm 1 will be restored with a temporary restoration on the day of surgery.

Implants in Arm 2 will receive healing caps immediately after surgery and a provisional restoration will be placed between day 28 to day 34 post-surgery.

In both arms, the final restoration will be placed between 140 and 160 days (20 to 23 weeks) post-surgery.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SLActive

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females must be at least 18 years of age
* Have at least one missing tooth in positions FDI 4, 5, 6, or 7 in any quadrant (ADA positions 2, 3, 4, 5; or 12, 13, 14, 15; or 20, 21, 22, 23; or 28, 29, 30, 31.)
* Subjects desire an implant supported restoration on1 to 4 implants per quadrant
* The tooth/teeth position(s) at the proposed implant site must have been extracted or lost at least 4 months before the date of implantation and be fully healed
* Adequate bone quality and quantity at the implant site to permit the insertion of a Straumann standard 4.1 mm diameter implant of at least 8 mm length without the use of concurrent bone augmentation techniques. If more bone is available and is indicated a Straumann standard 4.8 mm diameter implant with a wide neck of at least 8 mm length may be used, i.e. implant insertion sites must have sufficient bone height such that the implant will not encroach on vital structures and sufficient width that a minimum of 1 mm of bone lingual and buccal bone will remain
* The opposing dentition must be natural teeth or fixed crowns or bridges on natural teeth or implants. Removable prostheses or dentures opposing the study implants are not allowed
* Patients must be committed to the study for its full duration.

Exclusion Criteria

* Presence of conditions requiring chronic routine prophylactic use of antibiotics (e.g., history of rheumatic heart disease, bacterial endocarditis, cardiac valvular anomalies, prosthetic joint replacements)
* Medical conditions requiring prolonged use of steroids
* History of leukocyte dysfunction and deficiencies
* History of bleeding disorders
* History of neoplastic disease requiring the use of chemotherapy
* History of radiation therapy to the head and neck
* Patients with history of renal failure
* Patients with severe or uncontrolled metabolic bone disorders
* Uncontrolled endocrine disorders
* Physical handicaps that would interfere with the ability to perform adequate oral hygiene
* Use of any investigational drug or device within the 30 day period immediately prior to implant surgery on study day 0
* Alcoholism or drug abuse
* Patients infected with HIV
* Patients who smoke \>10 cigarettes per day or cigar equivalents, or who chew tobacco
* Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, or unreliability
* Local inflammation, including untreated periodontitis
* Mucosal diseases such as erosive lichen planus
* History of local irradiation therapy
* Presence of osseous lesions
* Unhealed extraction sites (less than 4 months post extraction of teeth in intended sites)
* Bone surgery (bone grafts, guided tissue regeneration techniques for bone enhancement) prior to implant placement unless performed more than 6 months prior to implant placement and the site fully healed. Note: Minor bone enhancement using harvested bone from the implant site and a resorbable membrane is allowed at the time of implant placement
* Patients requiring bone grafting at the surgical sites at the time of surgery.
* Severe bruxing or clenching habits
* Persistent intraoral infection
* Lack of primary stability of one (or more) implant(s) at surgery. In this instance the patient must be withdrawn and the patient treated accordingly
* Patients with inadequate oral hygiene or unmotivated for adequate home care
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Straumann AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Axel Zöllner, DDS

Role: PRINCIPAL_INVESTIGATOR

Private Universität Witten/ Herdecke

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Private Practice

Boca Raton, Florida, United States

Site Status

Private Practice

Indianapolis, Indiana, United States

Site Status

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Tiroler Landeskrankenanstaltengesellschaft mbH

Innsbruck, , Austria

Site Status

Praxisklinik fur Mund- Keifer- und Gesichtschirurgie

Bochum, , Germany

Site Status

Private Practice

Fürth, , Germany

Site Status

Klinikum Nord-Heidberg

Hamburg, , Germany

Site Status

Private Practice

Weiden, , Germany

Site Status

Private Universitat Witten

Witten, , Germany

Site Status

Queens University

Belfast, , Ireland

Site Status

Dublin Dental Hospital

Dublin, , Ireland

Site Status

Rijnland Hospital

Leiderdorp, , Netherlands

Site Status

Faculdade de medicina de coimbra

Coimbra, , Portugal

Site Status

Private Practice

Porto, , Portugal

Site Status

Private Practice

Barcelona, , Spain

Site Status

Private Practice

Málaga, , Spain

Site Status

Clinica Periobalear

Palma de Mallorca, , Spain

Site Status

Private Practice

Falun, , Sweden

Site Status

Private Practice

Sankt Gallen, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Austria Germany Ireland Netherlands Portugal Spain Sweden Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Zollner A, Ganeles J, Korostoff J, Guerra F, Krafft T, Bragger U. Immediate and early non-occlusal loading of Straumann implants with a chemically modified surface (SLActive) in the posterior mandible and maxilla: interim results from a prospective multicenter randomized-controlled study. Clin Oral Implants Res. 2008 May;19(5):442-50. doi: 10.1111/j.1600-0501.2007.01517.x.

Reference Type RESULT
PMID: 18416725 (View on PubMed)

Ganeles J, Zollner A, Jackowski J, ten Bruggenkate C, Beagle J, Guerra F. Immediate and early loading of Straumann implants with a chemically modified surface (SLActive) in the posterior mandible and maxilla: 1-year results from a prospective multicenter study. Clin Oral Implants Res. 2008 Nov;19(11):1119-28. doi: 10.1111/j.1600-0501.2008.01626.x.

Reference Type RESULT
PMID: 18983314 (View on PubMed)

Nicolau P, Korostoff J, Ganeles J, Jackowski J, Krafft T, Neves M, Divi J, Rasse M, Guerra F, Fischer K. Immediate and early loading of chemically modified implants in posterior jaws: 3-year results from a prospective randomized multicenter study. Clin Implant Dent Relat Res. 2013 Aug;15(4):600-12. doi: 10.1111/j.1708-8208.2011.00418.x. Epub 2011 Dec 15.

Reference Type RESULT
PMID: 22171722 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CR 06/03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Immediate Versus Late Placement
NCT04741607 RECRUITING NA